Precision For Medicine

Authority in utilizing human primary biological tissue and cells in research and drug discovery. Developer of translational biomarkers for Phase I/II clinical programs in autoimmunity, inflammation and cancer. Expert in phenotypic cell-based assays using multiple primary cell systems such as T/Th17/T-regs, NK-T, B/Plasma/Plasmablasts, Myeloid cells... , Dendritic cells (pDCc/mDCs), and MDSCs. Strategist in multi-parametric single-cell flow cytometry and analysis of flow cytometry data. Broad network of contacts at clinical sites and research hospitals, experienced with IRB submissions and clinical protocols. Scientific leader for Precisions Biomaterials commercial sourcing. To learn more about how Precision is transforming research please visit: precisionformedicine.com All of the company's products are intended only for research or manufacturing use unless otherwise arranged. Products are not to be used for human therapeutics or for any other purposes such as in vitro diagnostic uses, in foods, drugs, medical devices, or cosmetics for humans or animals, or for commercial use. Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, the company helps the company's pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment. © 2020 Precision For Medicine, Inc. All rights reserved.Read More